I need to prepare a PPT presentation for a conference (in spanish please the slides) it shall have this content: 📑 Slide-by-Slide Content MappingSection 1: Introduction (3 Mins)Slide 1: Title Slide – Keep it clean. Role of Cardiac MRI in Pericardial Disease. 2. Slide 2: Echo Limitations vs. CMR Strengths – Use a 2-column layout. Left: Where echo struggles (loculated effusions, tissue characterisation, thickening assessment). Right: Where CMR excels. Slide 3: Literature Backbone – Introduce Conte 2023 and Baser 2026 to show current consensus on moving from tier-1 imaging (echo) to advanced tier-2 imaging (CMR).Section 2: CMR Protocol (4 Mins) Slide 4: The Pericardial CMR Toolkit – Create a simple grid layout matching sequences to their pathology:Cine: Ventricular interdependence, septal bounce (constriction).T2-W / STIR: Edema (acute inflammation).Late Gadolinium Enhancement (LGE): Fibrosis, neovascularisation, chronic inflammation.Mapping (T1/T2): Quantitative tissue assessment (Wang 2022). Slide 5-6: Visual Examples – Show a multi-panel layout of a normal vs. abnormal pericardium across these sequences using short, looping GIFs or high-quality stills.Section 3: Phenotypes & Active Cases (8 Mins) Slide 7: Phenotypic Spectrum – Brief transition slide listing Acute, Effusive, and Constrictive phenotypes (Wang 2022, Baser 2026). Slide 8-9: Phenotype 1 (Acute/Recurrent) + Case 1 – Present a case of acute pericarditis. Show bright T2-STIR and intense pericardial LGE. Highlight the clinical takeaway: LGE thickness correlates with recurrence risk. Slide 10-11: Phenotype 2 (Constrictive Pericarditis) + Case 2 – Present a case of constrictive pericarditis. Use a Cine video clip to showcase the respiratory septal bounce and free-breathing sequences.Section 4: Imaging-Guided Management (6 Mins)Slide 12: Reversible vs. Fixed Constriction – Detail how CMR distinguishes transient/inflammatory constriction (high T2/LGE signal that responds to anti-inflammatories) from fixed fibrotic constriction (low T2, low LGE, thick pericardium) requiring surgery (Schenone 2025, Lertnimittham 2025). Slide 13: Risk Stratification – Use data from Antonopoulos 2023 to outline how CMR guides the duration of anti-inflammatory therapies (NSAIDs, Colchicine, Anakinra). Slide 14: Follow-up Under Therapy – Show a "Before vs. After" slide demonstrating a patient's reduction in pericardial LGE and edema after targeted medical management.Section 5: Rare Disease Presentation (3 Mins) Slide 15-17: Case 3 (IgG4-Related Pericardial Disease) – Start with the clinical mystery (e.g., massive unexplained effusion or pseudotumour mass). Show the CMR images tracking the diffuse thickening and avid LGE. Connect it to the final histopathology/serology to close out your cases with a high-impact narrative.Section 6: Conclusion (1 Min) Slide 18: Summary Bullet Points – Make these highly actionable for the clinicians in the audience.
I need to prepare a PPT presentation for a conference (in spanish please the slides) it shall have this content:
📑 Slide-by-Slide Content MappingSection
1: Introduction (3 Mins)Slide 1: Title Slide – Keep it clean. Role of Cardiac MRI in Pericardial Disease.
2. Slide 2: Echo Limitations vs. CMR Strengths – Use a 2-column layout. Left: Where echo struggles (loculated effusions, tissue characterisation, thickening assessment). Right: Where CMR excels.
Slide 3: Literature Backbone – Introduce Conte 2023 and Baser 2026 to show current consensus on moving from tier-1 imaging (echo) to advanced tier-2 imaging (CMR).Section 2: CMR Protocol (4 Mins)
Slide 4: The Pericardial CMR Toolkit – Create a simple grid layout matching sequences to their pathology:Cine: Ventricular interdependence, septal bounce (constriction).T2-W / STIR: Edema (acute inflammation).Late Gadolinium Enhancement (LGE): Fibrosis, neovascularisation, chronic inflammation.Mapping (T1/T2): Quantitative tissue assessment (Wang 2022).
Slide 5-6: Visual Examples – Show a multi-panel layout of a normal vs. abnormal pericardium across these sequences using short, looping GIFs or high-quality stills.Section 3: Phenotypes & Active Cases (8 Mins)
Slide 7: Phenotypic Spectrum – Brief transition slide listing Acute, Effusive, and Constrictive phenotypes (Wang 2022, Baser 2026).
Slide 8-9: Phenotype 1 (Acute/Recurrent) + Case 1 – Present a case of acute pericarditis. Show bright T2-STIR and intense pericardial LGE. Highlight the clinical takeaway: LGE thickness correlates with recurrence risk.
Slide 10-11: Phenotype 2 (Constrictive Pericarditis) + Case 2 – Present a case of constrictive pericarditis. Use a Cine video clip to showcase the respiratory septal bounce and free-breathing sequences.Section 4: Imaging-Guided Management (6 Mins)Slide 12: Reversible vs. Fixed Constriction – Detail how CMR distinguishes transient/inflammatory constriction (high T2/LGE signal that responds to anti-inflammatories) from fixed fibrotic constriction (low T2, low LGE, thick pericardium) requiring surgery (Schenone 2025, Lertnimittham 2025).
Slide 13: Risk Stratification – Use data from Antonopoulos 2023 to outline how CMR guides the duration of anti-inflammatory therapies (NSAIDs, Colchicine, Anakinra).
Slide 14: Follow-up Under Therapy – Show a "Before vs. After" slide demonstrating a patient's reduction in pericardial LGE and edema after targeted medical management.Section 5: Rare Disease Presentation (3 Mins)
Slide 15-17: Case 3 (IgG4-Related Pericardial Disease) – Start with the clinical mystery (e.g., massive unexplained effusion or pseudotumour mass). Show the CMR images tracking the diffuse thickening and avid LGE. Connect it to the final histopathology/serology to close out your cases with a high-impact narrative.Section 6: Conclusion (1 Min)
Slide 18: Summary Bullet Points – Make these highly actionable for the clinicians in the audience.
Created using ChatSlide
La resonancia magnética (RM) cardíaca juega un papel crucial en la evaluación de enfermedades pericárdicas, ayudando a identificar inflamación y constricción. Complementando a la ecocardiografía, que es la primera línea para detectar derrames y evaluar taponamientos, la RM ofrece ventajas en la caracterización tisular. La evidencia reciente, como los estudios de Conte 2023 y Baser 2026, respalda la integración de imágenes avanzadas y un modelo escalonado de evaluación, donde la...